The effects of fungal volatile organic compounds on bone marrow stromal cells

Canadian Journal of Microbiology

Volumn 60, Issue 1, 2014, Pages 1-4

  Hokeness, Kirsten ^a   Kratch, Jacqueline ^a   Nadolny, Christina ^a   Aicardi, Kristie ^a   Reid, Christopher W ^a  

^a BRYANT UNIVERSITY   (United States)

Author keywords

Bone marrow stromal cells; Cytotoxicity; Membrane lipids; Mold associated volatiles; Volatile organic compounds

Indexed keywords

1 OCTEN 3 OL; 2 OCTENAL; CHOLESTEROL; CYTOTOXIC AGENT; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

BONE; DISEASE; FUNGAL DISEASE; IMMUNE SYSTEM; MEMBRANE; VOLATILE ORGANIC COMPOUND;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW STROMAL CELL; CELL MEMBRANE; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; DROSOPHILA; EMBRYO; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; SURVIVAL RATE;

EID: 84891869105     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/cjm-2013-0708     Document Type: Article

References (29)

1. Araki, A., Kanazawa, A., Kawai, T., Eitaki, Y., Morimoto, K., Nakayama, K., et al. 2012. The relationship between exposure to microbial volatile organic compound and allergy prevalence in single-family homes. Sci. Total Environ. 423: 18-26. doi:10.1016/j.scitotenv.2012.02.026.
2. Bialecki, R.A., Tulenko, T.N., and Colucci, W.S. 1991. Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells. J. Clin. Invest. 88(6): 1894-1900. doi:10.1172/JCI115512.
3. Bligh, E.G., and Dyer, W.J. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37(8): 911-917. doi:10.1139/o59-099.
4. Cooper, R.A. 1978. Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells. J. Supramol. Struct. 8(4): 413-430. doi:10.1002/jss.400080404.
5. Enríquez-Matas, A., Quirce, S., Hernández, E., Vereda, A., Carnés, J., and Sastre, J. 2007. Hypersensitivity pneumonitis caused by domestic exposure to molds. J. Investig. Allergol. Clin. Immunol. 17(2): 126-127.
6. Gleason, M.M., Medow, M.S., and Tulenko, T.N. 1991. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ. Res. 69(1): 216-227. doi:10.1161/ 01.RES.69.1.216.
7. Gniadecki, R. 2004. Depletion of membrane cholesterol causes ligandindependent activation of Fas and apoptosis. Biochem. Biophys. Res. Commun. 320(1): 165-169. doi:10.1016/j.bbrc.2004.05.145.
8. Hodgson, M. 2000. Sick building syndrome. Occup. Med. 15(3): 571-585.
9. Hossain, M.A., Ahmed, M.S., and Ghannoum, M.A. 2004. Attributes of Stachybotrys chartarum and its association with human disease. J. Allergy Clin. Immunol. 113(2): 200-208. doi:10.1016/j.jaci.2003.12.018.
10. Ichihara, K., and Fukubayashi, Y. 2010. Preparation of fatty acid methyl esters for gas-liquid chromatography. J. Lipid Res. 51(3): 635-640. doi:10.1194/jlr. D001065.
11. Inamdar, A.A., Masurekar, P., and Bennett, J.W. 2010. Neurotoxicity of fungal volatile organic compounds in Drosophila melanogaster. Toxicol. Sci. 117(2): 418-426. doi:10.1093/toxsci/kfq222.
12. Inamdar, A.A., Moore, J.C., Cohen, R.I., and Bennett, J.W. 2012a. A model to evaluate the cytotoxicity of the fungal volatile organic compound 1-octen-3-ol in human embryonic stem cells. Mycopathologia, 173(1): 13-20. doi:10.1007/ s11046-011-9457-z.
13. Inamdar, A.A., Zaman, T., Morath, S.U., Pu, D.C., and Bennett, J.W. 2012b. Drosophila melanogaster as a model to characterize fungal volatile organic compounds. Environ. Toxicol. In press. doi:10.1002/tox.21825.
14. Institute of Medicine Committee on Damp Indoor Spaces and Health. 2004. Damp indoor spaces and health. The National Academies Press, Washington, D.C., USA.
15. Jaakkola, M.S., and Jaakkola, J.J.K. 2007. Office work exposures and adult-onset asthma. Environ. Health Perspect. 115(7): 1007-1011. doi:10.1289/ehp.9875.
16. Joshi, S.M. 2008. The sick building syndrome. Indian J. Occup. Environ. Med. 12(2): 61-64. doi:10.4103/0019-5278.43262.
17. Korpi, A., Järnberg, J., and Pasanen, A.L. 2009. Microbial volatile organic compounds. Crit. Rev. Toxicol. 39(2): 139-193. doi:10.1080/10408440802291497.
18. Kreja, L., and Seidel, H.J. 2002a. Evaluation of the genotoxic potential of some microbial volatile organic compounds (MVOC) with the comet assay, the micronucleus assay and the HPRT gene mutation assay. Mutat. Res. 513(1-2): 143-150. doi:10.1016/S1383-5718(01)00306-0.
19. Kreja, L., and Seidel, H.J. 2002b. On the cytotoxicity of some microbial volatile organic compounds as studied in the human lung cell line A549. Chemosphere, 49(1): 105-110. doi:10.1016/S0045-6535(02)00159-5.
20. Rocha, O., Ansari, K., and Doohan, F.M. 2005. Effects of trichothecene mycotoxins on eukaryotic cells: a review. Food Addit. Contam. 22(4): 369-378. doi:10. 1080/02652030500058403.
21. Ryan, T.J., and Beaucham, C. 2013. Dominant microbial volatile organic compounds in 23 US homes. Chemosphere, 90(3): 977-985. doi:10.1016/j. chemosphere.2012.06.066.
22. Sahlberg, B., Gunnbjörnsdottir, M., Soon, A., Jogi, R., Gislason Wieslander, G., et al. 2013. Airborne molds and bacteria, microbial volatile organic compounds (MVOC), plasticizers and formaldehyde in dwellings in three North European cities in relation to sick building syndrome (SBS). Sci. Total Environ. 444: 433-440. doi:10.1016/j.scitotenv.2012.10.114.
23. Sergent, O., Pereira, M., Belhomme, C., Chevanne, M., Huc, L., and Lagadic-Gossmann, D. 2005. Role for membrane fluidity in ethanol-induced oxidative stress of primary rat hepatocytes. J. Pharmacol. Exp. Ther. 313(1): 104-111.
24. Shoemaker, R.C., and House, D.E. 2006. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Neurotoxicol. Teratol. 28(5): 573-588. doi:10.1016/j.ntt.2006.07.003.
25. Straus, D.C. 2009. Molds, mycotoxins, and sick building syndrome. Toxicol. Ind. Health, 25(9-10): 617-635. doi:10.1177/0748233709348287.
26. USEPA. 2008. Sick building syndrome. US Environmental Protection Agency, Department of Research and Development.
27. WHO. 2009. WHO guidelines for indoor air quality: dampness and mold. World Health Organization Report, Germany.
28. Wolfe, C.H.J. 2011. Innate immunity and the pathogenicity of inhaled microbial particles. Int. J. Biol. Sci. 7(3): 261-268. doi:10.7150/ijbs.7.261.
29. Zhu, J., Wong, S.L., and Cakmak, S. 2013. Nationally representative data of selected volatile organic compounds in Canadian residential indoor air: a population based survey. Environ. Sci. Technol. In press. doi:10.1021/es403055e.